Mesenchymal stromal cells express GARP/LRRC32 on their surface: Effects on their biology and immunomodulatory capacity

Stem Cells

Volumn 33, Issue 1, 2015, Pages 183-195

  Carrillo Galvez, Ana Belén ^a   Cobo, Marién ^a   Cuevas Ocaña, Sara ^a   Gutiérrez Guerrero, Alejandra ^a   Sánchez Gilabert, Almudena ^a   Bongarzone, Pierpaolo ^a   García Pérez, Angélica ^a   Muñoz, Pilar ^b   Benabdellah, Karim ^a   Toscano, Miguel G ^a   Martín, Francisco ^a   Anderson, Per ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b NONE

Author keywords

Glycoprotein A repetitions predominant; Immunomodulation; Leucine rich repeat containing 32; Membrane bound TGF 1; Mesenchymal stem cells; Proliferation

Indexed keywords

GARP PROTEIN; LATENCY ASSOCIATED PEPTIDE; LENTIVIRUS VECTOR; MEMBRANE PROTEIN; PLASMID DNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LRRC32 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLOGY; DATA ANALYSIS SOFTWARE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOMODULATION; IN VITRO STUDY; KRUSKAL WALLIS TEST; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGENERATIVE MEDICINE; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THERAPY EFFECT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; IMMUNOMODULATION; MALE; MEMBRANE PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C;

EID: 84919429316     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1821     Document Type: Article

References (58)

1. Galipeau J,. The mesenchymal stromal cells dilemma-Does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 2013; 15: 2-8.
2. Herreros MD, Garcia-Arranz M, Guadalajara H, et al. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: A phase III randomized clinical trial (FATT 1: Fistula Advanced Therapy Trial 1) and long-term evaluation. Dis Colon Rectum 2012; 55: 762-772.
3. Blobe GC, Schiemann WP, Lodish HF,. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358.
4. Oshimori N, Fuchs E,. The harmonies played by TGF-beta in stem cell biology. Cell Stem Cell 2012; 11: 751-764.
5. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
6. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
7. Patel SA, Meyer JR, Greco SJ, et al. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: Role of mesenchymal stem cell-derived TGF-beta. J Immunol 2010; 184: 5885-5894.
8. Salazar KD, Lankford SM, Brody AR,. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1002-1011.
9. Ng F, Boucher S, Koh S, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008; 112: 295-307.
10. Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009; 15: 757-765.
11. Gentry LE, Nash BW,. The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 1990; 29: 6851-6857.
12. Miyazono K, Hellman U, Wernstedt C, et al. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem 1988; 263: 6407-6415.
13. Taipale J, Miyazono K, Heldin CH, et al. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994; 124: 171-181.
14. Annes JP, Munger JS, Rifkin DB,. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116: 217-224.
15. Ollendorff V, Noguchi T, deLapeyriere O, et al. The GARP gene encodes a new member of the family of leucine-rich repeat-containing proteins. Cell Growth Differ 1994; 5: 213-219.
16. Stockis J, Colau D, Coulie PG, et al. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009; 39: 3315-3322.
17. Tran DQ, Andersson J, Wang R, et al. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009; 106: 13445-13450.
18. Gandhi R, Anderson DE, Weiner HL,. Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner. J Immunol 2007; 178: 4017-4021.
19. Li H, Han Y, Guo Q, et al. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009; 182: 240-249.
20. Nakamura K, Kitani A, Strober W,. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194: 629-644.
21. Wang R, Wan Q, Kozhaya L, et al. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS One 2008; 3: e2705.
22. Edwards JP, Fujii H, Zhou AX, et al. Regulation of the expression of GARP/latent TGF-beta1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation. J Immunol 2013; 190: 5506-5515.
23. Wang R, Zhu J, Dong X, et al. GARP regulates the bioavailability and activation of TGFbeta. Mol Biol Cell 2012; 23: 1129-1139.
24. Fonseka M, Ramasamy R, Tan BC, et al. Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line). Cell Biol Int 2012; 36: 793-801.
25. Mokarizadeh A, Delirezh N, Morshedi A, et al. Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling. Immunol Lett 2012; 147: 47-54.
26. Cobo M, Anderson P, Benabdellah K, et al. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis. Cell Transplant 2013; 22: 839-854.
27. Anderson P, Carrillo-Galvez AB, Garcia-Perez A, et al. CD105 (Endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One 2013; 8: e76979.
28. Toscano MG, Frecha C, Ortega C, et al. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies. Gene Ther 2004; 11: 956-961.
29. Toscano MG, Frecha C, Benabdellah K, et al. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein. Hum Gene Ther 2008; 19: 179-197.
30. Toscano MG, Anderson P, Munoz P, et al. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: A human cellular model for Wiskott-Aldrich syndrome. Dis Model Mech 2013; 6: 544-554.
31. Barbet R, Peiffer I, Hatzfeld A, et al. Comparison of gene expression in human embryonic stem cells, hESC-derived mesenchymal stem cells and human mesenchymal stem cells. Stem Cells Int 2011; 2011: 368192.
32. Chan DV, Somani AK, Young AB, et al. Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32). BMC Biochem 2011; 12: 27.
33. Glinka Y, Prud'homme GJ,. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 2008; 84: 302-310.
34. Oida T, Weiner HL,. Overexpression of TGF-beta1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-beta. J Immunol 2010; 185: 3529-3535.
35. Gauthy E, Cuende J, Stockis J, et al. GARP is regulated by miRNAs and controls latent TGF-beta1 production by human regulatory T cells. PLoS One 2013; 8: e76186.
36. Fierro FA, Kalomoiris S, Sondergaard CS, et al. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 2011; 29: 1727-1737.
37. Kurpinski K, Lam H, Chu J, et al. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 2010; 28: 734-742.
38. Zhou AX, Kozhaya L, Fujii H, et al. GARP-TGF-beta complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo. J Immunol 2013; 190: 5057-5064.
39. Zhou Q, Haupt S, Prots I, et al. miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J Immunol 2013; 190: 6579-6588.
40. Ostroukhova M, Qi Z, Oriss TB, et al. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 2006; 116: 996-1004.
41. Shi M, Zhu J, Wang R, et al. Latent TGF-beta structure and activation. Nature 2011; 474: 343-349.
42. Han Y, Guo Q, Zhang M, et al. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 2009; 182: 111-120.
43. Zhang M, Xu S, Han Y, et al. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-beta. Hepatology 2011; 53: 306-316.
44. Pap E, Pallinger E, Falus A,. The role of membrane vesicles in tumorigenesis. Crit Rev Oncol Hematol 2011; 79: 213-223.
45. Dabovic B, Chen Y, Colarossi C, et al. Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability. J Cell Biol 2002; 156: 227-232.
46. Flaumenhaft R, Abe M, Sato Y, et al. Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993; 120: 995-1002.
47. Kojima S, Nara K, Rifkin DB,. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 1993; 121: 439-448.
48. Koli K, Ryynanen MJ, Keski-Oja J,. Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells. Bone 2008; 43: 679-688.
49. Jian H, Shen X, Liu I, et al. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 2006; 20: 666-674.
50. Roostaeian J, Carlsen B, Simhaee D, et al. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells. J Surg Res 2006; 133: 76-83.
51. Tapp H, Deepe R, Ingram JA, et al. Adipose-derived mesenchymal stem cells from the sand rat: Transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type I rich extracellular matrix. Arthritis Res Ther 2008; 10: R89.
52. Bekri S, Adelaide J, Merscher S, et al. Detailed map of a region commonly amplified at 11q13->q14 in human breast carcinoma. Cytogenet Cell Genet 1997; 79: 125-131.
53. Maire G, Forus A, Foa C, et al. 11q13 alterations in two cases of hibernoma: Large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer 2003; 37: 389-395.
54. McBeath R, Pirone DM, Nelson CM, et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004; 6: 483-495.
55. Probst-Kepper M, Geffers R, Kroger A, et al. GARP: A key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2009; 13: 3343-3357.
56. Anderson P, Souza-Moreira L, Morell M, et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut 2013; 62: 1131-1141.
57. Shi M, Liu ZW, Wang FS,. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011; 164: 1-8.
58. Xu C, Yu P, Han X, et al. TGF-beta promotes immune responses in the presence of mesenchymal stem cells. J Immunol 2014; 192: 103-109.